we compared the infections encountered in 23 renal transplant patients given the monoclonal anti-t-cell antibody , orthoclone okt3 ( okt3 ) , for treatment of steroid-resistant rejection in 1986 and in 23 control patients from 1984 to 1985 with resistant rejection matched demographically , for severity of rejection and for risk factors predisposing to infection , who did not receive okt3 ;
C0733466
orthoclone okt3
C0085379
okt3